Old Web
English
Sign In
Acemap
>
authorDetail
>
Juergen Bernd Honegger
Juergen Bernd Honegger
Melanoma
Protein kinase B
Vemurafenib
Signal transduction
Pathology
2
Papers
4
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases.
2017
Journal of Clinical Oncology
Friedegund Meier
Andrea Forschner
B Klumpp
Keith T. Flaherty
Juergen Bernd Honegger
M. Witte
Antje Bornemann
Reinhard Dummer
Juergen Bauer
Ghazaleh Tabatabai
Benjamin Weide
Thomas K. Eigentler
Dirk Schadendorf
Leticia Quintanilla-Fend
Heike Niessner
Claus Garbe
Show All
Source
Cite
Save
Citations (0)
The PI3K inhibitor BKM120 has potent antitumor activity in melanoma brain metastases in vitro and in vivo.
2013
Journal of Clinical Oncology
Friedegund Meier
Heike Niessner
Jennifer Schmitz
Andreas Schmid
Carsten Calaminus
Bernd J. Pichler
Andrea Forschner
Keith T. Flaherty
Juergen Bernd Honegger
Reinhard Dummer
Ghazaleh Tabatabai
Benjamin Weide
Thomas K. Eigentler
Dirk Schadendorf
Leticia Quintanilla-Fend
Claus Garbe
Show All
Source
Cite
Save
Citations (4)
1